Oxford Nanopore Technologies News and Activities
Presence
Oxford Nanopore Technologies develops DNA and RNA analysis tools. It sells sequencing devices, sample preparation products, and data analysis software to researchers, healthcare providers, and industrial customers.
Oxford Nanopore Technologies products and services overview:
- DNA sequencing
- RNA sequencing
- Sample preparation
- Flow cells
- Analysis software
- Testing services
Revenue: ~$230 million
Employees: 1,200
Headquarters: Oxford, United Kingdom (UK)
Oxford Nanopore Technologies is one of the...
Oxford Nanopore Technologies is a company listed under the stock ticker ONT (GB).
Executives
View the org chart displaying its 43 main executives
Most searched biographies at Oxford Nanopore Technologies
- Francis Van Parys, Chief Executive Officer
- Kate Priestman, Senior Independent Director
- Guy Harmelin, Non Executive Director
Popular executive movements at Oxford Nanopore Technologies
- Andrew Watson will join the company as Chief Information Officer on Jun. 15, 2026 (posted on May 21 2026).
- Davide Manissero will join the company as Chief Medical Officer on Aug. 3, 2026 (posted on May 21 2026).
- Tina Leger will join the company as Chief People Officer in Jun. 2026 (posted on May 21 2026).
Click here to view some more movements at Oxford Nanopore Technologies
Create your alert
to follow the executive moves at Oxford Nanopore Technologies.
Biotechnology
Oxford Nanopore Technologies has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Oxford Nanopore Technologies
- Lonza and Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA Quality Control
- Oxford Nanopore strengthens executive leadership team
- London Calling 2026 Technology Update
- Werfen and Oxford Nanopore enter strategic collaboration to support development of advanced transplant assays
- Compatible ecosystem growth accelerates across oncology, pathogen and multi‑omics workflows
- Action for ME announces research study for ME and Long Covid
- Cepheid and Oxford Nanopore expand partnership following successful phase one collaboration
- Pioneering single-cell sequencing approaches to understand the 'dark matter' of our genome
- Oxford Nanopore and A.D.A.M. Innovations announce international collaboration to accelerate advanced genomic medicine in Japan
- ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing
- View more press releases Close
Social media about Oxford Nanopore Technologies
- Oxford Nanopore Technologies on Wikipedia, Google News & Yahoo Finance
- Oxford Nanopore Technologies on LinkedIn, X (Twitter) & YouTube
